510(k) Report

510(k) · Cleared

Recalled · 2006

Cobe Smarxt Optimin Surface Modified Hollow Fiber Membrane Oxygenator

K013480510(k) SpecialCleared Nov 16, 200128-day reviewClass II21 CFR 870.4350Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cobe Cardiovascular, Inc. · DTZ Oxygenator, Cardiopulmonary Bypass

Cleared on Nov 16, 2001 as substantially equivalent to K991452 (Cobe Cardiovascular, Inc., 1999) after a 28-day review. Its family tree reaches back 2 generations to 1996. It has been recalled 2 times.

Decided
Nov 16, 2001
Review
28 days
Class
Class II
Product code
DTZ
Recalls
2
Predicates
1

Its longest line of descent runs back 2 generations to K960074 (1996). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1997: 1 other ancestorK960074 · Capiox SX10 Hollow Fiber Oxygenator with Detachable Hardshell Venous Reservoir · Terumo Medical Corp. · 1996K991452 · Cobe Optimin Hollow Fiber Membrane Oxygenator · Cobe Cardiovascular, Inc. · 1999 · recalled1996199820002002
  1. Root · 2 generations backK960074 Capiox SX10 Hollow Fiber Oxygenator with Detachable Hardshell Venous…Terumo Medical Corp. · 1996
  2. 1 generation backK991452 Cobe Optimin Hollow Fiber Membrane OxygenatorCobe Cardiovascular, Inc. · 1999 · Recalled
  3. This deviceK013480 Cobe Smarxt Optimin Surface Modified Hollow Fiber Membrane OxygenatorCobe Cardiovascular, Inc. · 2001
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K960074Capiox SX10 Hollow Fiber Oxygenator with Detachable Hardshell Venous ReservoirTerumo Medical Corp.1996—
−1K991452Cobe Optimin Hollow Fiber Membrane OxygenatorCobe Cardiovascular, Inc.19992
0 (this device)K013480Cobe Smarxt Optimin Surface Modified Hollow Fiber Membrane OxygenatorCobe Cardiovascular, Inc.2001—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
FIG. 1 — Lineage of K013480, 1996–2001Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DTZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTZ device

  1. #1 K240934 Quantum Perfusion Blood Oxygenator ECC…score 14.3 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991452Cobe Optimin Hollow Fiber Membrane Oxygenator
Summary page 1
…xchanger CLASSIFICATION NAME: Cardiopulmonary Bypass Oxygenator Cardiopulmonary Bypass Heat Exchanger PREDICATE DEVICE: COBE Optimin Hollow Fiber Membrane Oxygenator, #K991452 DEVICE DESCRIPTION/INDICATIONS FOR USE The COBE SMARXT Optimin is a sterile device with non-pyrogenic fluid pathways, for single…
Cobe Cardiovascular, Inc.19992

Also cleared against K991452: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 26, 2006Not classifiedZ-1424-06OtherCooling and rewarming time is extended. Efficiency of the heat exchangers is reduced because many of the folds that are critical to heat exchange on the blood side of the units were blocked with a metalic material, thus decreasing the…
Jun 26, 2006Not classifiedZ-1427-06OtherCooling and rewarming time is extended. Efficiency of the heat exchangers is reduced because many of the folds that are critical to heat exchange on the blood side of the units were blocked with a metalic material, thus decreasing the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 3.0 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • 1 other device also cites its predicate K991452.

How does its category compare?

All DTZ devices

DTZ Oxygenator, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DTZ

2in 2025

2007: 42008: 32009: 92010: 22011: 42012: 92013: 92014: 52015: 92016: 32017: 22018: 32019: 52020: 52021: 52022: 22023: 52024: 32025: 22026 (partial year): 3
2007high 9 (2009) · low 2 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTZ

124in 2024

2007: 55 days median2008: 88 days median2009: 210 days median2011: 160 days median2012: 90 days median2013: 28 days median2014: 28 days median2015: 134 days median2016: 62 days median2018: 72 days median2019: 90 days median2020: 93 days median2021: 336 days median2023: 145 days median2024: 124 days median2026 (partial year): 137 days median
2007high 336 (2021) · low 28 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DTZ

1in 2025

2007: 72008: 52010: 12011: 132012: 142014: 22016: 12018: 2, 2 Class I2019: 12020: 32021: 1, 1 Class I2022: 62025: 1
2007high 14 (2012) · low 0 (2009)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · DTZ

976in 2025

2007: 1342008: 1052009: 522010: 1192011: 1902012: 2152013: 3462014: 7642015: 6582016: 4432017: 3882018: 3202019: 4892020: 4422021: 5952022: 5592023: 7382024: 5352025: 976
2007high 976 (2025) · low 52 (2009)2025

MAUDE reports naming product code DTZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074557134
20083885105
20099210052
20102—1119
2011416013190
201299014215
20139280346
20145282764
201591340658
20163621443
20172—0388
20183722 (2)320
20195901489
20205933442
202153361 (1)595
20222—6559
202351450738
202431240535
20252—1976
202631370—

What is it indicated for?

The COBE® SMARXT® Optimin™ is indicated for use in surgical

procedures requiring extracorporeal gas exchange support and blood

temperature control. It is intended to be used in procedures requiring a

maximum blood flow rate of 5 liters/min and lasting up to six hours.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K013480: Cobe Smarxt Optimin Surface Modified Hollow Fiber Membrane Oxygenator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K013480

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026